Beroni Group (Beroni Group) Investments And Advances : $0.00 Mil (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Beroni Group Investments And Advances?

Beroni Group's Investments And Advances for the quarter that ended in Jun. 2023 was $0.00 Mil.

Beroni Group's annual Investments And Advances declined from Dec. 2020 ($0.98 Mil) to Dec. 2021 ($0.00 Mil) but then stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil).

Beroni Group Investments And Advances Historical Data

The historical data trend for Beroni Group's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beroni Group Investments And Advances Chart

Beroni Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Investments And Advances

Get a 7-Day Free Trial

2.62

1.51

0.98

Beroni Group Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Investments And Advances	Get a 7-Day Free Trial									1.00	-	-	-	-

Beroni Group Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Beroni Group (Beroni Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Beroni Group Ltd (OTCPK:BNIGF) » Definitions » Investments And Advances

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhong Bei High Technology Industrial Park, Level 10, Building 11, Xiqing District, Tianjin, CHN, 300380

Website

https://www.beronigroup.com

Beroni Group Ltd is an Australia based company engaged in the sale of smoking control product (NicoBloc), air purifier, healthcare products and supplements, cosmetics and stem-cell therapies. It has organized its business into four core business areas: cell therapies, developing new anticancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and detection & diagnosis of infectious diseases. Its operating segment includes Nicobloc, Fogibloc air purifier, Olansi water filter, Health supplements, Cosmetic products, Viral diagnostic kits, and Technical advisory service. Geographically, it operates in China and Japan. The highest revenue is generated from the Nicobloc segment through the China region.